CellbXhealth (CLBX)

Sector:

Support

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 17.00p
  • 52 Week Low: 1.00p
  • Currency: UK Pounds
  • Shares Issued: 1,139.40m
  • Volume: 0
  • Beta: 0.24

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
70.90% above the market average70.90% above the market average70.90% above the market average70.90% above the market average70.90% above the market average
79.07% above the sector average79.07% above the sector average79.07% above the sector average79.07% above the sector average79.07% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
30.67% above the market average30.67% above the market average30.67% above the market average30.67% above the market average30.67% above the market average
84.42% above the sector average84.42% above the sector average84.42% above the sector average84.42% above the sector average84.42% above the sector average
Price Book Ratio
2.80% above the market average2.80% above the market average2.80% above the market average2.80% above the market average2.80% above the market average
54.43% above the sector average54.43% above the sector average54.43% above the sector average54.43% above the sector average54.43% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
60.82% below the market average60.82% below the market average60.82% below the market average60.82% below the market average60.82% below the market average
65.59% below the sector average65.59% below the sector average65.59% below the sector average65.59% below the sector average65.59% below the sector average
Price Chg 3m
82.74% below the market average82.74% below the market average82.74% below the market average82.74% below the market average82.74% below the market average
80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
40.68% above the market average40.68% above the market average40.68% above the market average40.68% above the market average40.68% above the market average
37.08% above the sector average37.08% above the sector average37.08% above the sector average37.08% above the sector average37.08% above the sector average
Momentum 20
22.93% above the market average22.93% above the market average22.93% above the market average22.93% above the market average22.93% above the market average
10.11% above the sector average10.11% above the sector average10.11% above the sector average10.11% above the sector average10.11% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
90.09% below the market average90.09% below the market average90.09% below the market average90.09% below the market average90.09% below the market average
97.65% below the sector average97.65% below the sector average97.65% below the sector average97.65% below the sector average97.65% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average
75.9% below the sector average75.9% below the sector average75.9% below the sector average75.9% below the sector average75.9% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
67.43% below the market average67.43% below the market average67.43% below the market average67.43% below the market average67.43% below the market average
88.24% below the sector average88.24% below the sector average88.24% below the sector average88.24% below the sector average88.24% below the sector average
Operating Profit Loss
87.59% below the market average87.59% below the market average87.59% below the market average87.59% below the market average87.59% below the market average
92.94% below the sector average92.94% below the sector average92.94% below the sector average92.94% below the sector average92.94% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
16.69% below the market average16.69% below the market average16.69% below the market average16.69% below the market average16.69% below the market average
57.65% below the sector average57.65% below the sector average57.65% below the sector average57.65% below the sector average57.65% below the sector average
Cash
7.21% above the market average7.21% above the market average7.21% above the market average7.21% above the market average7.21% above the market average
21.43% below the sector average21.43% below the sector average21.43% below the sector average21.43% below the sector average21.43% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
74.57% above the market average74.57% above the market average74.57% above the market average74.57% above the market average74.57% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CellbXhealth Market Data

Currency UK Pounds
Share Price 1.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 17.00p
52 Week Low 1.00p
Volume 0
Shares Issued 1,139.40m
Beta 0.24

CellbXhealth Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.42% below the market average19.42% below the market average19.42% below the market average19.42% below the market average19.42% below the market average
36.47% above the sector average36.47% above the sector average36.47% above the sector average36.47% above the sector average36.47% above the sector average
Price Trend
85.01% below the market average85.01% below the market average85.01% below the market average85.01% below the market average85.01% below the market average
87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average
Income Not Available
Growth
54.99% above the market average54.99% above the market average54.99% above the market average54.99% above the market average54.99% above the market average
56.82% above the sector average56.82% above the sector average56.82% above the sector average56.82% above the sector average56.82% above the sector average

CellbXhealth Dividends

No dividends found

Trades for 07-Jan-2026

Time Volume / Share Price
09:09 25,000 @ 1.03p
09:02 841 @ 1.03p
08:34 51,679 @ 1.04p
08:30 95,210 @ 1.04p

CellbXhealth Key Personnel

Chair Jan Groen

Top of Page